Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy Near the End of Life: First--and Third and Fourth (Line)--Do No Harm.

× No keyword cloud information.

6 in total

1. A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study.

Authors: Brice Chanez; François Bertucci; Marine Gilabert; Anne Madroszyk; Frédérique Rousseau; Delphine Perrot; Patrice Viens; Jean-Luc Raoul
Journal: Support Care Cancer Date: 2017-03-28 Impact factor: 3.603

2. End-of-life care in cancer patients: how much drug therapy and how much palliative care? Record linkage study in Northern Italy.

Authors: Giulio Formoso; Massimiliano Marino; Monica Guberti; Roberto Giuseppe Grilli
Journal: BMJ Open Date: 2022-05-06 Impact factor: 3.006

3. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.

Authors: Claribel Simmons; Donald C McMillan; Sharon Tuck; Cat Graham; Alistair McKeown; Mike Bennett; Claire O'Neill; Andrew Wilcock; Caroline Usborne; Kenneth C Fearon; Marie Fallon; Barry J Laird
Journal: Oncologist Date: 2019-04-11

Chemotherapy Near the End of Life: First--and Third and Fourth (Line)--Do No Harm.

1. A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study.

2. End-of-life care in cancer patients: how much drug therapy and how much palliative care? Record linkage study in Northern Italy.

3. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.

4. Physician Influence on Variation in Receipt of Aggressive End-of-Life Care Among Women Dying of Ovarian Cancer.

5. Scanning the Global Literature.

6. Cancer treatment in the last 6 months of life: when inaction can outperform action.